Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Evolus, Inc. | 141,571 | reported | 18 May 2022 | tx 16+621,504−98,000 |
| Revance Therapeutics, Inc. | 65,497 | reported | 22 May 2018 | tx 45+428,463−155,814 |
| HARROW, INC. | 1,000 | reported | 18 May 2026 | tx 4+19,805 |
| Harpoon Therapeutics, Inc. | 0 | reported | 11 Mar 2024 | tx 6+48,335−9,333 |
| ISTA PHARMACEUTICALS INC | 0 | reported | 06 Jun 2012 | tx 86+742,830−918,282 |
| DYNAVAX TECHNOLOGIES CORP | 0 | reported | 10 Feb 2026 | tx 7+59,950−59,950 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 May 2026 | PURCHASE | HARROW, INC. | 1,000 | 31.00 USD | first after silence |
| 10 Feb 2026 | OTHER | DYNAVAX TECHNOLOGIES CORP | 10,075 | — | |
| 10 Feb 2026 | OTHER | DYNAVAX TECHNOLOGIES CORP | 7,125 | — | deriv |
| 10 Feb 2026 | OTHER | DYNAVAX TECHNOLOGIES CORP | 42,750 | — | deriv |
| 20 Jun 2025 | GRANT_AWARD | HARROW, INC. | 7,339 | 0.00 USD | deriv |
| 11 Jun 2025 | GRANT_AWARD | DYNAVAX TECHNOLOGIES CORP | 1,439 | 0.00 USD | |
| 11 Jun 2025 | GRANT_AWARD | DYNAVAX TECHNOLOGIES CORP | 7,125 | 0.00 USD | deriv |
| 03 Feb 2025 | GRANT_AWARD | DYNAVAX TECHNOLOGIES CORP | 8,636 | — | deriv |
| 03 Feb 2025 | GRANT_AWARD | DYNAVAX TECHNOLOGIES CORP | 42,750 | 0.00 USD | deriv |
| 14 Jun 2024 | GRANT_AWARD | HARROW, INC. | 8,347 | 0.00 USD | deriv |
| 11 Mar 2024 | OTHER | Harpoon Therapeutics, Inc. | 5,000 | — | |
| 11 Mar 2024 | OTHER | Harpoon Therapeutics, Inc. | 2,033 | — | deriv |
| 11 Mar 2024 | OTHER | Harpoon Therapeutics, Inc. | 2,300 | — | deriv |
| 26 Jan 2024 | GRANT_AWARD | HARROW, INC. | 3,119 | 0.00 USD | deriv |
| 27 Nov 2023 | GRANT_AWARD | Harpoon Therapeutics, Inc. | 5,000 | 0.00 USD | |
| 22 Jun 2023 | GRANT_AWARD | Harpoon Therapeutics, Inc. | 23,000 | 0.00 USD | deriv |
| 15 Sept 2022 | GRANT_AWARD | Harpoon Therapeutics, Inc. | 20,335 | 0.00 USD | deriv |
| 17 May 2022 | SALE | Evolus, Inc. | 16,189 | 13.92 USD | |
| 18 May 2022 | SALE | Evolus, Inc. | 52,015 | 12.42 USD | |
| 08 Mar 2022 | SALE | Evolus, Inc. | 10,192 | 9.73 USD | |
| 24 Jan 2022 | GRANT_AWARD | Evolus, Inc. | 53,571 | 0.00 USD | |
| 24 Jan 2022 | GRANT_AWARD | Evolus, Inc. | 77,640 | 0.00 USD | deriv |
| 10 Aug 2021 | SALE | Evolus, Inc. | 14,293 | 11.18 USD | |
| 27 Jan 2021 | GRANT_AWARD | Evolus, Inc. | 90,000 | 0.00 USD | |
| 25 Jan 2021 | SALE | Evolus, Inc. | 2,699 | 7.46 USD |
3 purchases reported after at least 12 months of silence — most recent on 18 May 2026.